A nerve growth promoter and an antioxidant containing a degradation product obtained by degrading a composition containing a hyaluronic acid and a protein with a protease. A would treatment agent containing an ethyl acetate extract of a degradation product obtained by degrading a composition containing a hyaluronic acid and a protein with a protease.

A nerve growth promoter and an antioxidant containing a degradation product obtained by degrading a composition containing a hyaluronic acid and a protein with a protease. A would treatment agent containing an ethyl acetate extract of a degradation product obtained by degrading a composition containing a hyaluronic acid and a protein with a protease.

A method of performing an electrochemical assay, comprising: reducing oxygen interference by introducing a biochemical oxygen scavenger to reduce dissolved oxygen directly into water.

A method of performing an electrochemical assay, comprising: reducing oxygen interference by introducing a biochemical oxygen scavenger to reduce dissolved oxygen directly into water.

An olefinic polymer composition comprising at least one polyolefin, as well as a broadleaf tree lignin with pH below 7. The invention further relates to objects obtained from such a composition, and the use of broadleaf tree lignin with pH below 7 in the preparation of an olefinic polymer composition.

Methods of temporarily enhancing the luster and/or brilliance of a piece of jewelry, a gem stone, or a piece of jewelry including a gem stone including applying a non-aqueous composition to the piece of jewelry, the gem stone, or the piece of jewelry including a gem stone.

Methods of temporarily enhancing the luster and/or brilliance of a piece of jewelry, a gem stone, or a piece of jewelry including a gem stone including applying a non-aqueous composition to the piece of jewelry, the gem stone, or the piece of jewelry including a gem stone.

A nerve growth promoter and an antioxidant containing a degradation product obtained by degrading a composition containing a hyaluronic acid and a protein with a protease. A would treatment agent containing an ethyl acetate extract of a degradation product obtained by degrading a composition containing a hyaluronic acid and a protein with a protease.

A nitrogen stabilizing composition is provided. The composition includes 22 to 26% w/w N-(n-butyl) thiophosphoric triamide (NBPT), 4 to 8% w/w of 3,4-dimethyl pyrazole phosphate (DMPP) and/or nitrapyrin, a solvent including N-methyl-2-pyrrolidone (NMP) and propylene glycol, 0.1 to 5% w/w vegetable oil, and 0.1 to 5% w/w lecithin.

A nitrogen stabilizing composition is provided. The composition includes 22 to 26% w/w N-(n-butyl) thiophosphoric triamide (NBPT), 4 to 8% w/w of 3,4-dimethyl pyrazole phosphate (DMPP) and/or nitrapyrin, a solvent including N-methyl-2-pyrrolidone (NMP) and propylene glycol, 0.1 to 5% w/w vegetable oil, and 0.1 to 5% w/w lecithin.